VILDIABATE M 1000

Vildagliptin and metformin HCl tablets are prescription oral antidiabetic medicines used to improve blood glucose control in adults with type 2 diabetes mellitus when diet, exercise, and existing treatment do not provide adequate control. The combination contains two active ingredients—vildagliptin and metformin hydrochloride—that work through complementary mechanisms to help regulate blood glucose.

This fixed-dose combination may be prescribed when metformin alone is not providing sufficient glycaemic control, when a patient is already taking vildagliptin and metformin separately, or in selected patients alongside other diabetes medicines, including insulin. The exact product strength and treatment regimen should be determined by a qualified healthcare professional.

What Are Vildagliptin and Metformin HCl Tablets?

Vildagliptin and metformin HCl tablets combine two glucose-lowering medicines in one oral dosage form.

Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It helps enhance the body's incretin system, supporting glucose-dependent insulin release and reducing inappropriate glucagon secretion.

Metformin hydrochloride is a biguanide that improves insulin sensitivity and reduces hepatic glucose production. Together, the two medicines can provide complementary blood-glucose-lowering effects.

Approved combination products include strengths such as 50 mg/850 mg and 50 mg/1000 mg, although available strengths can vary by manufacturer and market. For example, a current UK Summary of Product Characteristics lists 50 mg vildagliptin with either 850 mg or 1000 mg metformin hydrochloride.

Vildagliptin and Metformin HCl Tablets Uses

The primary use of this combination is to improve glycaemic control in adults with type 2 diabetes alongside diet and exercise.

According to current European product information, the combination may be used in patients:

• Whose blood glucose is inadequately controlled with metformin alone

• Already taking vildagliptin and metformin as separate tablets

• Who require combination therapy with other diabetes medicines, including insulin, when existing treatment does not provide adequate glycaemic control

The medicine is not a replacement for healthy eating, physical activity, diabetes monitoring, or appropriate medical follow-up.

Is it used for type 1 diabetes?

No. Vildagliptin/metformin combination therapy is not intended to replace insulin in insulin-dependent patients and should not be used to treat type 1 diabetes.

How Do Vildagliptin and Metformin Work?

The two ingredients approach blood-glucose regulation differently.

How vildagliptin works

Vildagliptin inhibits DPP-4, an enzyme involved in breaking down incretin hormones. By increasing incretin activity, vildagliptin helps the pancreas release insulin when blood glucose is elevated and helps reduce glucagon secretion.

How metformin works

Metformin primarily reduces glucose production by the liver and improves insulin sensitivity. This allows the body to use insulin more effectively.

Why combine the two?

Using medicines with complementary mechanisms can improve glycaemic control when a single medicine is insufficient. The combination can also simplify treatment for patients who would otherwise need separate tablets.

However, combination treatment should be selected according to individual clinical needs rather than solely for convenience.

Key Benefits of Vildagliptin and Metformin HCl Tablets

When appropriately prescribed, the combination offers several potential therapeutic benefits.

1. Helps improve blood glucose control

The primary benefit is improved glycaemic control in adults with type 2 diabetes when lifestyle measures and existing therapy are insufficient.

2. Combines two complementary mechanisms

Vildagliptin and metformin work differently, allowing the combination to target glucose regulation through more than one pathway.

3. Can be used when metformin alone is insufficient

Patients whose type 2 diabetes remains inadequately controlled despite metformin may be considered for combination therapy when clinically appropriate.

4. May simplify treatment

A fixed-dose tablet can combine both active ingredients in a single dosage form, potentially reducing the number of separate tablets a patient needs.

5. Can be incorporated into broader diabetes treatment

In selected patients, the combination may be used with other antidiabetic medicines, including insulin, when additional glycaemic control is required.

Important: These benefits describe the therapeutic purpose of the medicine and do not guarantee a specific result for every patient.

Vildagliptin and Metformin HCl Dosage

There is no single dose that is appropriate for every patient.

The correct strength and schedule depend on the patient's existing treatment, glycaemic control, kidney function, tolerability, and other clinical factors.

Current product information for a 50 mg/850 mg formulation states that treatment should be individualized and that the maximum recommended daily vildagliptin dose is 100 mg. For adults with normal renal function, some approved combination regimens use one tablet in the morning and one in the evening, but the exact regimen depends on the patient's circumstances and prescribed product.

Patients should not increase, decrease, split, or discontinue the medicine on their own.

Because formulations differ, always check the strength printed on the package and follow the prescription supplied by the doctor.

How to Take Vildagliptin and Metformin HCl Tablets

Take the medicine exactly as prescribed.

Combination products containing metformin are commonly taken with or just after food, which can help reduce gastrointestinal symptoms associated with metformin.

Helpful medication habits include:

• Take doses at the same time each day.

• Follow the prescribed schedule.

• Do not take extra tablets if a dose is missed unless specifically instructed.

• Do not stop treatment because your blood glucose improves.

• Continue recommended diet and exercise measures.

• Attend scheduled diabetes follow-up appointments.

• Tell your healthcare professional about other medicines and supplements.

Vildagliptin and Metformin HCl Side Effects

Like all medicines, this combination can cause adverse effects.

Commonly reported reactions include:

• Nausea

• Diarrhoea

• Vomiting

• Abdominal pain

• Flatulence

• Constipation

• Headache

• Dizziness

• Tremor

• Upper respiratory tract infection

• Nasopharyngitis

• Rash or itching

• Sweating

• Joint pain

• Fatigue or weakness

Digestive symptoms are particularly relevant because metformin can cause gastrointestinal discomfort, especially when treatment is started or doses are changed.

Taking the medicine with or immediately after food may help reduce these symptoms.

Serious Side Effects and Safety Concerns

Although many adverse effects are mild, several uncommon or very rare complications require medical attention.

Lactic acidosis

Metformin can rarely cause lactic acidosis, a serious metabolic complication. The risk is particularly important when kidney function deteriorates or when other risk factors such as severe illness, dehydration, tissue hypoxia, excessive alcohol intake, or certain medicines are present.

Symptoms can include:

• Severe weakness

• Abdominal pain

• Muscle cramps

• Difficulty breathing

• Unusual sleepiness

• Feeling cold

• Confusion

These symptoms require urgent medical evaluation.

Liver problems

Vildagliptin has been associated with rare cases of hepatic dysfunction, including hepatitis. Product information recommends liver-function testing before treatment and regular monitoring during therapy.

Symptoms such as yellowing of the skin or eyes, dark urine, unusual tiredness, or persistent abdominal discomfort should be discussed promptly with a healthcare professional.

Pancreatitis

Vildagliptin has been associated with a risk of acute pancreatitis. Severe, persistent abdominal pain—particularly if it radiates toward the back—requires immediate medical assessment. If pancreatitis is confirmed, vildagliptin should not be restarted according to the cited product information.

Hypoglycaemia

The risk of low blood glucose is generally influenced by the other diabetes medicines being used. Hypoglycaemia can become more relevant when vildagliptin/metformin is combined with a sulfonylurea or insulin.

Possible symptoms include sweating, shaking, hunger, dizziness, confusion, weakness, and a fast heartbeat.

Kidney Function and Vildagliptin/Metformin

Kidney function is particularly important because metformin is eliminated through the kidneys.

Current product information recommends assessing GFR before starting metformin-containing treatment and monitoring renal function regularly. Metformin-containing vildagliptin combinations are contraindicated in severe renal impairment, including GFR below 30 mL/min in the cited product information.

People who are older or at increased risk of declining kidney function may require more frequent monitoring.

Patients should inform their doctor about kidney disease, dehydration, severe infection, vomiting, diarrhoea, or other acute illnesses.

Liver Function Monitoring

Liver health is also important with vildagliptin.

Product information recommends obtaining baseline liver-function tests and monitoring them periodically during treatment. Patients with hepatic impairment should not use the cited vildagliptin/metformin combination.

This makes professional assessment particularly important before starting treatment.

Vildagliptin and Metformin Drug Interactions

Vildagliptin/metformin can interact with other medicines or be affected by conditions that alter kidney function or blood glucose.

Important examples include:

• Certain diuretics

• ACE inhibitors

• Angiotensin II receptor blockers

• NSAIDs

• Corticosteroids

• Beta-2 agonists

• Other glucose-lowering medicines

• Alcohol

• Iodinated contrast agents used for certain imaging procedures

Iodinated contrast can affect kidney function and may increase metformin-related risks. Product information states that metformin should be discontinued before or at the time of certain intravascular iodinated contrast procedures and should not be restarted until kidney function has been reassessed and confirmed stable, typically after at least 48 hours.

Patients should always inform their doctor or pharmacist about all prescription medicines, over-the-counter products, supplements, and herbal preparations.

Vildagliptin and Metformin During Pregnancy and Breastfeeding

Pregnancy requires specialist medical advice.

The current product information reviewed here states that vildagliptin/metformin should not be used during pregnancy and breastfeeding because of insufficient human data and potential risks.

Anyone who is pregnant, planning pregnancy, or breastfeeding should speak with their healthcare professional before using or continuing this medicine.

Who Should Avoid or Use Extra Caution?

Vildagliptin and metformin HCl tablets may not be appropriate for people with certain conditions.

Tell your doctor if you have:

• Kidney disease

• Liver disease

• Heart or respiratory problems

• A history of pancreatitis

• Excessive alcohol use

• Severe dehydration

• A recent serious illness

• Diabetes-related ketoacidosis

• A planned surgical procedure

• Pregnancy or breastfeeding

The medicine is contraindicated in several serious conditions, including severe renal failure, hepatic impairment, acute metabolic acidosis, and certain conditions associated with tissue hypoxia.

Vildagliptin and Metformin HCl Tablets: Product & Purchase Considerations

For patients, pharmacies, distributors, and healthcare procurement teams searching for vildagliptin and metformin HCl tablets, product verification is important before purchase or supply.

Check:

• Active ingredients

• Strength, such as 50 mg/850 mg or 50 mg/1000 mg

• Manufacturer

• Batch number

• Manufacturing and expiry dates

• Packaging integrity

• Storage requirements

• Regulatory labeling

• Prescription requirements

• Supplier credentials

Because this is a prescription medicine, purchasing should be handled through a legitimate, authorized pharmaceutical supply or pharmacy channel appropriate to the applicable regulations.

Avoid purchasing products with unclear labeling, damaged packaging, missing batch information, or questionable sourcing.

Vildagliptin and Metformin HCl Tablets: Conclusion

Vildagliptin and metformin HCl tablets are combination oral medicines designed to improve blood glucose control in adults with type 2 diabetes when lifestyle measures and existing therapy are not sufficient. Vildagliptin and metformin provide complementary mechanisms, making the combination an established option for selected patients.

The key benefits include improved glycaemic control, combination therapy in a single tablet, and the ability to use the treatment in selected patients whose diabetes is inadequately controlled with metformin alone.

However, this is a prescription treatment—not a general-purpose diabetes supplement. Kidney and liver function should be assessed appropriately, and potential complications such as lactic acidosis, pancreatitis, hepatic dysfunction, and hypoglycaemia should be understood.

For safe and effective use, patients should follow their prescribed dose, maintain recommended lifestyle measures, attend regular diabetes monitoring appointments, and discuss all other medicines and health conditions with their healthcare professional.

Frequently Asked Questions 

1. What are vildagliptin and metformin HCl tablets used for?

They are used with diet and exercise to improve blood glucose control in adults with type 2 diabetes, particularly when metformin alone is not providing adequate control.

2. What is the benefit of combining vildagliptin with metformin?

The two medicines work through different mechanisms to help regulate blood glucose, providing combination therapy when one medicine may not be sufficient.

3. Are vildagliptin and metformin HCl tablets used for type 1 diabetes?

No. The combination is intended for type 2 diabetes and should not replace insulin in patients who require insulin.

4. How do vildagliptin and metformin work together?

Vildagliptin enhances incretin-related glucose regulation, while metformin primarily reduces liver glucose production and improves insulin sensitivity.

5. What strengths of vildagliptin and metformin tablets are available?

Common approved combination strengths include 50 mg/850 mg and 50 mg/1000 mg, although availability varies by product and country.

6. How should vildagliptin and metformin HCl tablets be taken?

Take them exactly as prescribed. Metformin-containing combination tablets are generally taken with or just after food to help reduce gastrointestinal symptoms.

7. What are the common side effects of vildagliptin and metformin?

Common adverse effects can include nausea, diarrhoea, vomiting, abdominal discomfort, headache, dizziness, rash, and other gastrointestinal or general symptoms.

8. Can vildagliptin and metformin cause low blood sugar?

They can contribute to hypoglycaemia, particularly when combined with medicines such as sulfonylureas or insulin.

9. Can vildagliptin and metformin cause stomach problems?

Yes. Metformin commonly causes gastrointestinal effects such as nausea, diarrhoea, abdominal discomfort, flatulence, or vomiting. Taking the medicine with or after food may help.

10. Can vildagliptin and metformin cause liver problems?

Rare hepatic dysfunction, including hepatitis, has been reported with vildagliptin. Liver-function monitoring is recommended according to product information.

11. Can vildagliptin cause pancreatitis?

Vildagliptin has been associated with acute pancreatitis. Severe or persistent abdominal pain should be evaluated urgently by a healthcare professional.

12. Are vildagliptin and metformin safe for people with kidney disease?

Kidney function is an important consideration because metformin is eliminated through the kidneys. Severe renal impairment can contraindicate metformin-containing treatment.

13. Can I drink alcohol while taking vildagliptin and metformin?

Excessive alcohol intake can increase the risk of metformin-associated lactic acidosis, particularly in the presence of fasting, malnutrition, or liver problems. Discuss alcohol use with your healthcare professional.

14. Can I take vildagliptin and metformin before a CT scan?

If iodinated contrast is being administered intravenously, special precautions may be required because of the potential effect on kidney function. Your healthcare team should know that you take metformin before the procedure.

15. Can vildagliptin and metformin be taken with insulin?

Yes, the combination may be used with insulin in selected adults with type 2 diabetes when additional glycaemic control is required.

16. Can I stop vildagliptin and metformin when my blood sugar improves?

Do not stop prescribed diabetes medicine without speaking with your doctor. Improved blood glucose may indicate that treatment is working rather than that treatment is no longer needed.

17. What happens if I miss a dose of vildagliptin and metformin?

Follow the missed-dose instructions supplied with your specific product. Do not take an extra dose unless your healthcare professional specifically tells you to do so.

18. Can vildagliptin and metformin be used during pregnancy?

The product information reviewed here states that the combination should not be used during pregnancy. Discuss pregnancy or plans to become pregnant with your healthcare professional.

19. Can vildagliptin and metformin be used while breastfeeding?

The cited product information states that the combination should not be used during breastfeeding. Ask your doctor about appropriate alternatives.

20. Is vildagliptin and metformin a prescription medicine?

Yes. These combination tablets are prescription medicines and should be used under appropriate medical supervision.

21. Can I buy vildagliptin and metformin HCl tablets online?

Availability depends on the country and applicable regulations. Because this is a prescription medicine, purchase should be through a legitimate, authorized pharmacy or pharmaceutical supplier that follows local prescription and dispensing requirements.

22. What should I check before buying vildagliptin and metformin HCl tablets?

Check the exact strength, active ingredients, manufacturer, batch details, expiry date, packaging, regulatory labeling, and supplier credentials. Do not purchase products with unclear provenance.

23. Does vildagliptin and metformin cure diabetes?

No. The medicine helps control blood glucose in type 2 diabetes but does not represent a guaranteed cure. Long-term diabetes management may include medication, nutrition, physical activity, weight management, and regular medical monitoring.

24. How long do vildagliptin and metformin tablets take to work?

Blood glucose may begin responding after treatment starts, but the overall effect should be evaluated through ongoing glucose monitoring and follow-up with the treating clinician.